Admelog FDA Approval History
FDA Approved: Yes (First approved December 11, 2017)
Brand name: Admelog
Generic name: insulin lispro
Dosage form: Injection
Company: Sanofi
Treatment for: Diabetes, Type 1, Diabetes, Type 2
Admelog (insulin lispro) is a follow-on rapid-acting human insulin analog (referenced to Humalog) for the treatment of patients with type 1 and type 2 diabetes.
Development timeline for Admelog
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
